Biological mechanisms associated with increased perseveration and hyperactivity in a genetic mouse model of neurodevelopmental disorder

Psychoneuroendocrinology

Volumn 38, Issue 8, 2013, Pages 1370-1380

  Trent, Simon ^a   Dean, Rachel ^b   Veit, Bonnie ^b   Cassano, Tommaso ^c   Bedse, Gaurav ^d   Ojarikre, Obah A ^e   Humby, Trevor ^a   Davies, William ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b CARDIFF UNIVERSITY   (United Kingdom)

^c UNIVERSITY OF FOGGIA   (Italy)

^d SAPIENZA UNIVERSITY OF ROME   (Italy)

^e NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

Author keywords

Acetylserotonin O methyltransferase; Attention deficit hyperactivity disorder; Autism; Dehydroepiandrosterone; Hippocampus; Locomotor activity; Serotonin; Spatial working memory; Steroid sulfatase; Xp22.3

Indexed keywords

ACETYLSEROTONIN METHYLTRANSFERASE; GENOMIC DNA; PRASTERONE; SEROTONIN; STEROID HORMONE; STERYL SULFATASE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASMT GENE; ATTENTION DEFICIT DISORDER; AUTISM; CHROMOSOME; CHROMOSOME 22; CHROMOSOME 39; CHROMOSOME 40; CHROMOSOME XP; CHROMOSOME XY; CLINICAL FEATURE; DEVELOPMENTAL DISORDER; DISEASE ASSOCIATION; DISEASE SEVERITY; FORAGING; GENE; GENETIC ANALYSIS; GENETIC MODEL; HORMONE ACTION; HORMONE BLOOD LEVEL; HYPERACTIVITY; IMPULSIVENESS; LOCOMOTION; MOLECULAR MECHANICS; MOUSE; NEUROLOGIC DISEASE; NONHUMAN; PERSEVERATION; PRIORITY JOURNAL; PROTEIN FUNCTION; REACTION TIME; SEROTONIN BRAIN LEVEL; SEX CHROMOSOME; STS GENE; TASK PERFORMANCE;

ACETYLSEROTONIN O-METHYLTRANSFERASE; ANIMALS; APPETITIVE BEHAVIOR; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; AUTISTIC DISORDER; DEHYDROEPIANDROSTERONE; EXPLORATORY BEHAVIOR; GENE DELETION; HIPPOCAMPUS; HYPERKINESIS; IMPULSIVE BEHAVIOR; MICE; MICE, MUTANT STRAINS; SEROTONIN; STERYL-SULFATASE;

EID: 84878657803     PISSN: 03064530     EISSN: 18733360     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2012.12.002     Document Type: Article

References (51)

1. Bambini-Junior V., Rodrigues L., Behr G.A., Moreira J.C., Riesgo R., Gottfried C. Animal model of autism induced by prenatal exposure to valproate: behavioral changes and liver parameters. Brain Res. 2011, 1408:8-16.
2. Boycott K.M., Parslow M.I., Ross J.L., Miller I.P., Bech-Hansen N.T., MacLeod P.M. A familial contiguous gene deletion syndrome at Xp22.3 characterized by severe learning disabilities and ADHD. Am. J. Med. Genet. A 2003, 122A:139-147.
3. Brigman J.L., Mathur P., Harvey-White J., Izquierdo A., Saksida L.M., Bussey T.J., Fox S., Deneris E., Murphy D.L., Holmes A. Pharmacological or genetic inactivation of the serotonin transporter improves reversal learning in mice. Cereb. Cortex 2010, 20:1955-1963.
4. Chaste P., Clement N., Botros H.G., Guillaume J.L., Konyukh M., Pagan C., Scheid I., Nygren G., Anckarsater H., Rastam M., Stahlberg O., Gillberg I.C., Melke J., Delorme R., Leblond C., Toro R., Huguet G., Fauchereau F., Durand C., Boudarene L., Serrano E., Lemiere N., Launay J.M., Leboyer M., Jockers R., Gillberg C., Bourgeron T. Genetic variations of the melatonin pathway in patients with attention-deficit and hyperactivity disorders. J. Pineal Res. 2011, 51:394-399.
5. Chocholska S., Rossier E., Barbi G., Kehrer-Sawatzki H. Molecular cytogenetic analysis of a familial interstitial deletion Xp22.2-22.3 with a highly variable phenotype in female carriers. Am. J. Med. Genet. A 2006, 140:604-610.
6. Dalland T. Response and stimulus perseveration in rats with septal and dorsal hippocampal lesions. J. Comp. Physiol. Psychol. 1970, 71:114-118.
7. Davies W. Does steroid sulfatase deficiency influence postpartum psychosis risk?. Trends Mol. Med. 2012, 18:256-262.
8. Davies W., Humby T., Kong W., Otter T., Burgoyne P.S., Wilkinson L.S. Converging pharmacological and genetic evidence indicates a role for steroid sulfatase in attention. Biol. Psychiatry 2009, 66:360-367.
9. de Visser L., Homberg J.R., Mitsogiannis M., Zeeb F.D., Rivalan M., Fitoussi A., Galhardo V., van den Bos R., Winstanley C.A., Dellu-Hagedorn F. Rodent versions of the Iowa gambling task: opportunities and challenges for the understanding of decision-making. Front. Neurosci. 2011, 5:109.
10. Dufour-Rainfray D., Vourc'h P., Le Guisquet A.M., Garreau L., Ternant D., Bodard S., Jaumain E., Gulhan Z., Belzung C., Andres C.R., Chalon S., Guilloteau D. Behavior and serotonergic disorders in rats exposed prenatally to valproate: a model for autism. Neurosci. Lett. 2010, 470:55-59.
11. Fischer M., Barkley R.A., Smallish L., Fletcher K. Executive functioning in hyperactive children as young adults: attention, inhibition, response perseveration, and the impact of comorbidity. Dev. Neuropsychol. 2005, 27:107-133.
12. Good M.A., Barnes P., Staal V., McGregor A., Honey R.C. Context- but not familiarity-dependent forms of object recognition are impaired following excitotoxic hippocampal lesions in rats. Behav. Neurosci. 2007, 121:218-223.
13. Harrison A.A., Everitt B.J., Robbins T.W. Doubly dissociable effects of median- and dorsal-raphe lesions on the performance of the five-choice serial reaction time test of attention in rats. Behav. Brain Res. 1997, 89:135-149.
14. Hermes G.L., Jacobs L.F., McClintock M.K. The sectored foraging field: a novel design to quantify spatial strategies, learning, memory, and emotion. Neurobiol. Learn. Mem. 2005, 84:69-73.
15. Humby T., Laird F.M., Davies W., Wilkinson L.S. Visuospatial attentional functioning in mice: interactions between cholinergic manipulations and genotype. Eur. J. Neurosci. 1999, 11:2813-2823.
16. Jamain S., Quach H., Betancur C., Rastam M., Colineaux C., Gillberg I.C., Soderstrom H., Giros B., Leboyer M., Gillberg C., Bourgeron T. Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism. Nat. Genet. 2003, 34:27-29.
17. Jonsson L., Ljunggren E., Bremer A., Pedersen C., Landen M., Thuresson K., Giacobini M., Melke J. Mutation screening of melatonin-related genes in patients with autism spectrum disorders. BMC Med. Genomics 2010, 3:10.
18. Kasahara T., Abe K., Mekada K., Yoshiki A., Kato T. Genetic variation of melatonin productivity in laboratory mice under domestication. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:6412-6417.
19. Kent L., Emerton J., Bhadravathi V., Weisblatt E., Pasco G., Willatt L.R., McMahon R., Yates J.R. X-linked ichthyosis (steroid sulfatase deficiency) is associated with increased risk of attention deficit hyperactivity disorder, autism and social communication deficits. J. Med. Genet. 2008, 45:519-524.
20. Korf H.W., Von Gall C., Stehle J. The circadian system and melatonin: lessons from rats and mice. Chronobiol. Int. 2003, 20:697-710.
21. Laumonnier F., Bonnet-Brilhault F., Gomot M., Blanc R., David A., Moizard M.P., Raynaud M., Ronce N., Lemonnier E., Calvas P., Laudier B., Chelly J., Fryns J.P., Ropers H.H., Hamel B.C., Andres C., Barthelemy C., Moraine C., Briault S. X-linked mental retardation and autism are associated with a mutation in the NLGN4 gene, a member of the neuroligin family. Am. J. Hum. Genet. 2004, 74:552-557.
22. Le Pen G., Grottick A.J., Higgins G.A., Moreau J.L. Phencyclidine exacerbates attentional deficits in a neurodevelopmental rat model of schizophrenia. Neuropsychopharmacology 2003, 28:1799-1809.
23. Lonardo F., Parenti G., Luquetti D.V., Annunziata I., Della Monica M., Perone L., De Gregori M., Zuffardi O., Brunetti-Pierri N., Andria G., Scarano G. Contiguous gene syndrome due to an interstitial deletion in Xp22.3 in a boy with ichthyosis, chondrodysplasia punctata, mental retardation and ADHD. Eur. J. Med. Genet. 2007, 50:301-308.
24. Maruki K., Izaki Y., Hori K., Nomura M., Yamauchi T. Effects of rat ventral and dorsal hippocampus temporal inactivation on delayed alternation task. Brain Res. 2001, 895:273-276.
25. Mehler-Wex C., Riederer P., Gerlach M. Dopaminergic dysbalance in distinct basal ganglia neurocircuits: implications for the pathophysiology of Parkinson's disease, schizophrenia and attention deficit hyperactivity disorder. Neurotox. Res. 2006, 10:167-179.
26. Melke J., Goubran Botros H., Chaste P., Betancur C., Nygren G., Anckarsater H., Rastam M., Stahlberg O., Gillberg I.C., Delorme R., Chabane N., Mouren-Simeoni M.C., Fauchereau F., Durand C.M., Chevalier F., Drouot X., Collet C., Launay J.M., Leboyer M., Gillberg C., Bourgeron T. Abnormal melatonin synthesis in autism spectrum disorders. Mol. Psychiatry 2008, 13:90-98.
27. Mortaud S., Nicolas L., Pinoteau W., Tordjman S., Carlier M., Roubertoux P.L. Brain pathways mediating the pro-aggressive effect of the steroid sulfatase (Sts) gene. Behav. Genet. 2010, 40:211-219.
28. Muir J.L., Everitt B.J., Robbins T.W. The cerebral cortex of the rat and visual attentional function: dissociable effects of mediofrontal, cingulate, anterior dorsolateral, and parietal cortex lesions on a five-choice serial reaction time task. Cereb. Cortex 1996, 6:470-481.
29. Narita N., Kato M., Tazoe M., Miyazaki K., Narita M., Okado N. Increased monoamine concentration in the brain and blood of fetal thalidomide- and valproic acid-exposed rat: putative animal models for autism. Pediatr. Res. 2002, 52:576-579.
30. Nicolas L.B., Pinoteau W., Papot S., Routier S., Guillaumet G., Mortaud S. Aggressive behavior induced by the steroid sulfatase inhibitor COUMATE and by DHEAS in CBA/H mice. Brain Res. 2001, 922:216-222.
31. Oades R.D. Role of the serotonin system in ADHD: treatment implications. Expert Rev. Neurother. 2007, 7:1357-1374.
32. Odorisio T., Rodriguez T.A., Evans E.P., Clarke A.R., Burgoyne P.S. The meiotic checkpoint monitoring synapsis eliminates spermatocytes via p53-independent apoptosis. Nat. Genet. 1998, 18:257-261.
33. O'Hare A. Autism spectrum disorder: diagnosis and management. Arch. Dis. Child. Educ. Pract. Ed. 2009, 94:161-168.
34. Pearce J.M., George D.N., Haselgrove M., Erichsen J.T., Good M.A. The influence of hippocampal lesions on the discrimination of structure and on spatial memory in pigeons (Columba livia). Behav. Neurosci. 2005, 119:1316-1330.
35. Reed M.J., Purohit A., Woo L.W., Newman S.P., Potter B.V. Steroid sulfatase: molecular biology, regulation, and inhibition. Endocr. Rev. 2005, 26:171-202.
36. Rhoads D.E., Grimes N., Kaushal S., Mallari J., Orlando K. Decision time and perseveration of adolescent rats in the T-maze are affected differentially by buspirone and independent of 5-HT-1A expression. Pharmacol. Biochem. Behav. 2012, 102:58-63.
37. Rhodes M.E., Li P.K., Burke A.M., Johnson D.A. Enhanced plasma DHEAS, brain acetylcholine and memory mediated by steroid sulfatase inhibition. Brain Res. 1997, 773:28-32.
38. Robbins T.W. The 5-choice serial reaction time task: behavioural pharmacology and functional neurochemistry. Psychopharmacology (Berl.) 2002, 163:362-380.
39. Rommelse N.N., Franke B., Geurts H.M., Hartman C.A., Buitelaar J.K. Shared heritability of attention-deficit/hyperactivity disorder and autism spectrum disorder. Eur. Child Adolesc. Psychiatry 2010, 19:281-295.
40. Scott M.M., Deneris E.S. Making and breaking serotonin neurons and autism. Int. J. Dev. Neurosci. 2005, 23:277-285.
41. Shinawi M., Patel A., Panichkul P., Zascavage R., Peters S.U., Scaglia F. The Xp contiguous deletion syndrome and autism. Am. J. Med. Genet. A 2009, 149A:1138-1148.
42. Shull R.N., Holloway F.A. Behavioral effects of hippocampal system lesions on rats in an operant paradigm. Brain Res. Bull. 1985, 14:315-322.
43. Stergiakouli E., Langley K., Williams H., Walters J., Williams N.M., Suren S., Giegling I., Wilkinson L.S., Owen M.J., O'Donovan M.C., Rujescu D., Thapar A., Davies W. Steroid sulfatase is a potential modifier of cognition in attention deficit hyperactivity disorder. Genes Brain Behav. 2011, 10:334-344.
44. Strous R.D., Spivak B., Yoran-Hegesh R., Maayan R., Averbuch E., Kotler M., Mester R., Weizman A. Analysis of neurosteroid levels in attention deficit hyperactivity disorder. Int. J. Neuropsychopharmacol. 2001, 4:259-264.
45. Thapar A., Cooper M., Jefferies R., Stergiakouli E. What causes attention deficit hyperactivity disorder?. Arch. Dis. Child. 2012, 97:260-265.
46. Thomas N.S., Sharp A.J., Browne C.E., Skuse D., Hardie C., Dennis N.R. Xp deletions associated with autism in three females. Hum. Genet. 1999, 104:43-48.
47. Trent S., Cassano T., Bedse G., Ojarikre O.A., Humby T., Davies W. Altered serotonergic function may partially account for behavioral endophenotypes in steroid sulfatase-deficient mice. Neuropsychopharmacology 2012, 37:1267-1274.
48. Trent S., Dennehy A., Richardson H., Ojarikre O.A., Burgoyne P.S., Humby T., Davies W. Steroid sulfatase-deficient mice exhibit endophenotypes relevant to attention deficit hyperactivity disorder. Psychoneuroendocrinology 2012, 37:221-229.
49. Tsuchiya E., Oki J., Yahara N., Fujieda K. Computerized version of the Wisconsin card sorting test in children with high-functioning autistic disorder or attention-deficit/hyperactivity disorder. Brain Dev. 2005, 27:233-236.
50. Vorstman J.A., Staal W.G., van Daalen E., van Engeland H., Hochstenbach P.F., Franke L. Identification of novel autism candidate regions through analysis of reported cytogenetic abnormalities associated with autism. Mol. Psychiatry 2006, 11(1):18-28.
51. Wang L.J., Huang Y.S., Hsiao C.C., Chiang Y.L., Wu C.C., Shang Z.Y., Chen C.K. Salivary dehydroepiandrosterone, but not cortisol, is associated with attention deficit hyperactivity disorder. World J. Biol. Psychiatry 2011, 12:99-109.